SARAH RILEY: Open Payments
NPI 1902260920 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,814 in 83 payments from 8 companies in 2025. Trend: 2023 $340 · 2024 $3,802 · 2025 $19,814
Speaker / faculty: $11,025Travel & lodging: $5,131Food & beverage: $2,188Consulting: $1,470
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 72 | $19,535 |
| SCPHARMACEUTICALS INC. | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 1 | $44 |
| Alnylam Pharmaceuticals Inc. | 1 | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $44 |
| Invivyd Inc | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
Products named: Attruby, FUROSCIX, WAINUA, AMVUTTRA, LifeVest, PEMGARDA, LEQVIO, Kerendia.
Industry payments across MD — which companies pay providers there.
